Page last updated: 2024-11-04

gatifloxacin and Arteriosclerosis

gatifloxacin has been researched along with Arteriosclerosis in 2 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Muhlestein, JB1
Mitchell, WM1
Stratton, CW1

Reviews

1 review available for gatifloxacin and Arteriosclerosis

ArticleYear
Antibiotic treatment of atherosclerosis.
    Current opinion in lipidology, 2003, Volume: 14, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; C-Reactive Protein; Cardiovascular D

2003

Other Studies

1 other study available for gatifloxacin and Arteriosclerosis

ArticleYear
Chlamydia pneumoniae and acute coronary syndrome.
    The New England journal of medicine, 2005, Aug-04, Volume: 353, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; Chlamydophila Infections; Chlamydoph

2005